An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

NCT07217860 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression
Bipolar I Disorder
Bipolar Disorder
Bipolar II Disorder

Interventions

DRUG: Azetukalner

Sponsor

Xenon Pharmaceuticals Inc.